Your session is about to expire
← Back to Search
Potassium Citrate + Crystal Light for Kidney Stones
N/A
Recruiting
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 7 of week 5
Awards & highlights
No Placebo-Only Group
Summary
This trial examines whether crystal light, potassium citrate, or both can help reduce urinary stone risk factors in patients with a history of stones and low pH.
Who is the study for?
This trial is for men and women aged 18-80 with a history of kidney stones and low urine citrate or pH levels. Participants must be able to follow the study plan, collect their urine for testing, sign consent forms, have normal blood work results, and not have severe hypocitraturia or other specific health issues.
What is being tested?
The study aims to understand how potassium citrate alone, Crystal Light lemonade alone, or both combined affect factors in the urine that contribute to kidney stone formation in people who've had stones before and have low urinary citrate/pH.
What are the potential side effects?
Possible side effects may include gastrointestinal discomfort due to potassium citrate or reactions related to ingredients in Crystal Light. However, specifics on side effects are not provided; participants should discuss potential risks with the research team.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 7 of week 5
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 7 of week 5
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
urine citrate levels
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Active Control
Group I: Potassium citrateActive Control1 Intervention
Group II: Crystal lightActive Control1 Intervention
Group III: Crystal light + potassium citrateActive Control1 Intervention
Find a Location
Who is running the clinical trial?
Northwestern UniversityLead Sponsor
1,647 Previous Clinical Trials
958,559 Total Patients Enrolled
5 Trials studying Kidney Stones
600 Patients Enrolled for Kidney Stones
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am between 18 and 80 years old.I have conditions like high potassium, uncontrolled diabetes, kidney disease, adrenal problems, slow stomach emptying, stomach ulcers, or a UTI.I am part of a vulnerable patient group.I am unable to make my own medical decisions.I have a kidney condition called distal renal tubular acidosis or it's caused by my medication.I am allergic to ingredients in Crystal Light.I have completed a Litholink test with blood work results available.Your urine pH level is less than 5.6.You have very low levels of citrate in your urine.Your potassium, BUN, creatinine, eGFR, and hemoglobin A1c levels are in the normal range.If you have low levels of citrate in your urine.
Research Study Groups:
This trial has the following groups:- Group 1: Potassium citrate
- Group 2: Crystal light
- Group 3: Crystal light + potassium citrate
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Learn More About These Treatments
Share this study with friends
Copy Link
Messenger